These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 19695398)

  • 1. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost containment through pharmaceutical procurement: a Caribbean case study.
    Huff-Rousselle M; Burnett F
    Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for STD management in developing countries: choice, procurement, cost, and financing.
    Van der Veen F; Fransen L
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S166-74. PubMed ID: 10023369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
    Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
    Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
    Hamzah NM; Perera PN; Rannan-Eliya RP
    BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the availability and cost of medicines in the private sector in Mali].
    Maïga MD; Diawara A
    Med Trop (Mars); 2006 Dec; 66(6):565-8. PubMed ID: 17286022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, price and affordability of asthma medicines in five Indian states.
    Kotwani A
    Int J Tuberc Lung Dis; 2009 May; 13(5):574-9. PubMed ID: 19383189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The logical underpinnings and benefits of pooled pharmaceutical procurement: a pragmatic role for our public institutions?
    Huff-Rousselle M
    Soc Sci Med; 2012 Nov; 75(9):1572-80. PubMed ID: 22835922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand?
    Tordoff JM; Norris PT; Reith DM
    Value Health; 2005; 8(3):201-8. PubMed ID: 15877592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the World Bank's pharmaceutical lending.
    Rodríguez-Monguió R; Rovira J; Seoane-Vázquez E
    Health Policy; 2007 Apr; 81(1):102-16. PubMed ID: 16824640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
    [No Abstract]   [Full Text] [Related]  

  • 16. Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme.
    Karnon J; Edney L; Sorich M
    Aust Health Rev; 2017 Mar; 41(1):1-6. PubMed ID: 26954612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hospital pioneers reform of its state's procurement code.
    Keating TP
    J Healthc Resour Manag; 1997 Apr; 15(3):14-20. PubMed ID: 10167013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International prices and availability of pharmaceuticals in 2005.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negotiating antiretroviral drug prices: the experience of the Andean countries.
    Seoane-Vazquez E; Rodriguez-Monguio R
    Health Policy Plan; 2007 Mar; 22(2):63-72. PubMed ID: 17299024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-procurement in the Brazilian healthcare system: the impact of joint drug purchases by a hospital network.
    Sigulem F; Zucchi P
    Rev Panam Salud Publica; 2009 Nov; 26(5):429-34. PubMed ID: 20107694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.